2-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

Catalog No. :
ACBEVA034
CAS No. :
2924710-37-0
Molecular Formula :
C15H20BN3O3
Molecular Weight :
301.16

IUPAC Name:2-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

2-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$313.00Login to see priceIn stockInquiry
250mg95%$625.00Login to see priceIn stockInquiry
500mg95%$938.00Login to see priceIn stockInquiry
1g95%$1562.00Login to see priceIn stockInquiry
5g95%$4686.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
IUPAC Name2-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one
Molecular FormulaC15H20BN3O3
Molecular Weight301.16
SMILESO=C1N(C)N=CN1C2=CC=C(B3OC(C)(C(C)(C)O3)C)C=C2
InChI KeyNXKCEXHRTBAXTD-UHFFFAOYSA-N
CAS No.2924710-37-0

Synthetic Route by SureRoute

1. ACBEVA034 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. ACAIQY317 route compound structure diagram
    ACAIQY317530080-66-1 In Stock
  4. Then
  5. ACBEVA034 route product structure diagram
    ACBEVA0342924710-37-0 In Stock
Inquiry

2. ACBEVA034 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRDMB803 route compound structure diagram
    ACRDMB8034114-20-9 In Stock
  4. Then
  5. ACBEVA034 route product structure diagram
    ACBEVA0342924710-37-0 In Stock
Inquiry

Comments (0)